Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (GILD) Company Bio
Gilead Sciences is a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
GILD Stock Chart More Charts
GILD Price/Volume Stats
| Current price | $63.59 |
| Prev. close | $62.80 |
| Day low | $62.05 |
| Day high | $63.76 |
| 50-day MA | $65.07 |
| 200-day MA | $70.11 |
| 52-week high | $79.61 |
| 52-week low | $60.32 |
| Volume | 2,756,021 |
| Avg. volume | 7,389,714 |
| Dividend yield | 4.01% |
| Market Cap | 81.07B |
GILD Returns
| 1-mo | -1.01% |
| 3-mo | -6.81% |
| 6-mo | -7.16% |
| 1-year | -10.20% |
| 3-year | -32.14% |
| 5-year | -4.49% |
| YTD | 2.65% |
| 2018 | -9.92% |
| 2017 | 2.96% |
| 2016 | -27.59% |
| 2015 | 8.63% |
| 2014 | 25.51% |
GILD Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...